Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2018 April;109(2) > Minerva Medica 2018 April;109(2):103-15



Publication history
Per citare questo articolo


Rivista di Medicina Interna

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878




Minerva Medica 2018 April;109(2):103-15

DOI: 10.23736/S0026-4806.17.05488-X


lingua: Inglese

Residual renal and cardiovascular disease risk in conventionally-treated patients with type 2 diabetes: the potential of non-traditional biomarkers

Karima ZITOUNI 1, Mia STEYN 2, Kenneth A. EARLE 2, 3

1 Infection and Immunity Institute, St George’s University of London, London, UK; 2 Thomas Addison Diabetes Unit, St George’s University Hospitals NHS Foundation Trust, London, UK; 3 Institute of Medical and Biomedical Education, St George’s University of London, London, UK


Diabetes is a leading cause of chronic kidney disease (CKD) in the developed world. Promoters of the progression of kidney disease include the traditional profile of cardiovascular risk factors. However, the development of CKD and vulnerability to end-stage renal disease (ESRD) is highly variable. Determinants of the susceptibility to ESRD may include non-traditional risk factors such as gene-environment interactions, socio-geographic factors and/or treatment strategies. We review the conflicting clinical relevance of studies implicating pathways related to oxidative stress. These pathways are strongly implicated in the phenotype of some groups of high-risk patients and could assume importance in clinical care. Recent clinical trial evidence has shown that newer glucose-lowering agents also have beneficial effects on reducing the incidence of renal dysfunction and cardiovascular events in high-risk patients. Research is required to identify which patients will benefit most from newer approaches to managing diabetes. Understanding the relationship of non-traditional risk factors to renal and cardiovascular disease could help clinicians targeting new therapeutic approaches in the management of type 2 diabetes.

KEY WORDS: Type 2 diabetes mellitus - Kidney diseases - Cardiovascular diseases - Etiology - Endothelium - Oxidative stress

inizio pagina

Publication History

Issue published online: March 9, 2018
Article first published online: November 21, 2017
Manuscript accepted: November 13, 2017
Manuscript received: November 10, 2017

Per citare questo articolo

Zitouni K, Steyn M, Earle KA. Residual renal and cardiovascular disease risk in conventionally-treated patients with type 2 diabetes: the potential of non-traditional biomarkers. Minerva Med 2018;109:103-15. DOI: 10.23736/S0026-4806.17.05488-X

Corresponding author e-mail